Nancy Hughes
Internal Medicine · Galveston, TXNPI 1225197791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $721 and has fallen 82.0% since, to $130 in 2022.
Across 106 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$372
- Amgen$271
- AstraZeneca$234
- Takeda Pharmaceuticals U.S.A., Inc.$207
- Lilly USA, LLC$205
- Merz North America, Inc.$168
- plus $462 from 14 others
What the payments were for
- Food & beverage$1,82895%
- Education$925%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $372 |
| Amgen | 16 | $271 |
| AstraZeneca | 15 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $207 |
| Lilly USA, LLC | 15 | $205 |
| Merz North America, Inc. | 2 | $168 |
| Bayer | 3 | $87 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Boehringer Ingelheim | 3 | $54 |
| Ascensia Diabetes Care US Inc. | 2 | $40 |
| Johnson & Johnson | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Pfizer | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$163
How this compares
$1,919 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Galveston
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.